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Background: Little is known about multidrug-resistant Pseudomonas aeruginosa (MDRP)
outbreaks in long-term care facilities (LTCFs).
Aim: To describe an MDRP outbreak in an LTCF and to clarify risk factors for MDRP
acquisition.
Methods: Patients who were positive for MDRP at an LTCF from January 2013 to January
2014 were analysed. A descriptive analysis, a caseecontrol study, and a microbiological
analysis were performed.
Findings: A total of 23 MDRP cases were identified, 16 of which were confirmed in sputum
samples. Healthcare workers were observed violating hand hygiene procedures when
performing oral, wound, and genital care. Nasogastric tube and oxygen mask use was
associated with MDRP acquisition in the respiratory tract, which might have been
confounded by poor hand hygiene. Sharing unhygienic devices, such as portable oral
suction devices for oral care, and washing bottles and ointments for wound and genital
care with inadequate disinfection could explain the transmission of MDRP in some cases.
Isolates from 11 patients were found to be indistinguishable or closely related by pulsed-
field gel electrophoresis and harbouring the blaGES-5 gene. Subsequent enhanced infection
control measures were supported by nearby hospitals and a local public health centre. No
additional cases were identified for a year after the last case occurred in January 2014.Institute of Infectious Diseases, Infectious Disease Surveillance Centre, 1-23-1 Toyama, Shinjuku,
1.
agishi).
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A. Kanayama et al. / Journal of Hospital Infection 93 (2016) 35e4136Conclusion: An outbreak of MDRP with an antimicrobial resistance gene, blaGES-5, occurred
in a Japanese LTCF. It was successfully controlled by enhanced infection control measures,
which neighbouring hospitals and a local public health centre supported.
ª 2016 The Authors. Published by Elsevier Ltd
on behalf of the Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Multidrug-resistant Pseudomonas aeruginosa (MDRP),
defined as strains of P. aeruginosa resistant to carbapenems,
fluoroquinolones, and aminoglycosides, is one of the most
important healthcare-associated pathogens.1 MDRP infection
is associated with increased mortality, and treatment options
are limited. Although MDRP outbreaks among critically ill pa-
tients have been reported at tertiary care and university
hospitals in developed countries, there is no published infor-
mation on MDRP outbreaks in long-term care facilities (LTCFs)
or nursing homes.2 Due to resource limitations, infection
control for multidrug-resistant organisms (MDROs), including
MDRP, is difficult to implement in such facilities, even in
developed countries. This situation presents a serious problem
for countries such as Japan, where the population is ageing,
and where more LTCFs are expected to open in the near
future.
In January 2014, a cluster of patients in an LTCF from which
MDRP had been isolated was reported to the public health
centre in Takatsuki City, Japan. An investigation was con-
ducted by Takatsuki City and the National Institute of Infec-
tious Diseases. We herein report the successful control of the
outbreak by a unique LTCF-supporting system that was imple-
mented by neighbouring hospitals and a local public health
centre.Methods
Overview of the hospital
This investigation was conducted in an LTCF with 225 beds
and six wards. In 2013, the hospital hadw150 hospitalizations
per month. The average period of hospitalization per patient
was 86 days. The average inpatient age was 75 years. Clinical
specimens were sent to a commercial laboratory, as the hos-
pital did not have a microbiology laboratory on site.Epidemiological investigation
A case was defined as a patient from whom MDRP was iso-
lated in the period from January 2013 to January 2014. Stool,
wound, and urethral catheter screening cultures were ob-
tained from all hospitalized patients in January 2014. Both
infection and colonization were considered as a case. Data
were collected from patients’ medical records, interviews with
healthcare workers, and ward inspections. If a case was found
to have stayed in the sameward as another case for at least one
day, then those cases were considered to have anepidemiologic link. Environmental samples were obtained from
affected wards between September and November 2013.
Microbiological analyses
P. aeruginosa strains from patient and environmental
samples were isolated in a commercial laboratory (Falco Bio-
systems, Kyoto, Japan). The isolates were confirmed as
P. aeruginosa using biochemical characterization and amatrix-
assisted laser desorptioneionization time-of-flight (MALDI-
TOF) mass spectrometry system (MALDI Biotyper version 3.0.0,
Bruker Daltonics, Germany). Drug susceptibility tests were
performed by a broth micro-dilution method according to the
standards of the Clinical and Laboratory Standards Institute.3
The production of metallo-b-lactamase (MBL) and Klebsiella
pneumoniae carbapenemase (KPC) was determined by a
combination disc test using imipenem/EDTA, and imipenem or
meropenem/3-aminophenyl boronic acid, respectively.4,5 A
multiplex polymerase chain reaction (PCR) was performed to
screen for carbapenemase genes, blaVEB, blaGES, blaPER, bla-
VIM, blaIMP, blaKPC, and blaOXA-48-like, as described previously.
6
The blaGES-like genes were amplified with the GES-1f (50-
ATGCGCTTCATTCACGC-30) and MultiGES_rev (50-TTTGTCC
GTGCTCAGGAT-30) primers using standard PCR conditions.6
The amplified fragments were sequenced with an ABI 3130
Genetic Analyzer (Life Technologies, Carlsbad, CA, USA). The
826 bp sequence data (with primer sequences omitted) were
analysed using the BLAST program against the GenBank data-
base. The aac(60)-like genes, an aminoglycoside-resistant
gene, were detected using PCR, sequenced, and identified
by a BLAST analysis.7 Pulsed-field gel electrophoresis (PFGE)
was performed with SpeI restriction enzyme (Roche Di-
agnostics, Mannheim, Germany), as described previously.8
PFGE profiles were analysed using the Bionumerics software
program (Applied Maths, Sint-Martens-Latem, Belgium;
version 6.6) with the Dice-coefficient represented by the un-
weighted pair group method with arithmetic mean (UPGMA),
1% optimization and 0.6% tolerance. Furthermore, relatedness
among isolates was evaluated with criteria previously devel-
oped by Tenover et al.9
Caseecontrol study
A caseecontrol study was conducted to identify risk factors
for acquiring MDRP in the respiratory tract. A case was defined
as a hospitalized patient in whom MDRP was detected in a
sputum sample taken from January to December 2013. Patients
who were found to be positive for MDRP during the first two
days of admission were excluded. The control group included
patients who were hospitalized in the two-week period before
or after the hospitalization of a matched case and whose
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were randomly selected from the laboratory database and
matched on admission date. The observation period for a case
(time at risk) was from the date of admission to the date of
MDRP specimen collection.10 The observation period for a
control was from the date of admission to the date on which a
negative specimen was obtained. Maximum length of the
observation period was three months. Comorbidities among
cases were classified into three categories using the McCabe
score, in which non-fatal, ultimately fatal, and rapidly pro-
gressive diseases are categorized as I, II, and III, respectively.11
Odds ratios for each factor were calculated and adjusted by
time at risk and McCabe score, as these variables may have
confounding effects.10
Statistical analyses
The ManneWhitney U-test and Fisher’s exact test were
conducted as appropriate. Two-tailed P < 0.05 was considered
to indicate statistical significance. The Stata 13 software pro-
gram (StataCorp., College Station, TX, USA) was used for all
statistical analyses.
Ethical considerations
The present investigation was conducted as part of a public
health response to an outbreak. Neither informed consent from
patients nor bioethical review was required from the associ-
ated institutions.
Results
Descriptive epidemiology
A total of 23 MDRP cases (male: N ¼ 17, 74%; female: N ¼ 6,
26%) were identified in five wards of the LTCF (Figure 1). Their
median age was 79 years (Table I). All cases had underlying
medical conditions, and nearly half (11 cases, 48%) were
admitted with pneumonia. In 16 (70%) of 23 cases, MDRP was
isolated from sputum samples. Ten (43%) cases were admitted
to the internal medicine ward. The initial case was identified in
the internal medicine ward in January 2013, with subsequent
cases identified every month between March 2013 and January
2014. The median period between admission date and obtain-
ing a positive MDRP isolate was 68 days. Eight cases developed
infections with MDRP (pneumonia, N ¼ 7; wound infection,
N ¼ 1). Although 11 of the patients died (48%), no deaths were
directly attributable to MDRP infection. Five clusters of cases
with epidemiologic links were found in four different wards
(Figure 1, Table I). The first case in each cluster had no
epidemiologic link to any case outside of the cluster, and the
outpatient case had no link to any other case; however, two
cases from different clusters and with MDRP-positive sputum
samples received oral care with the same portable oral suction
devices (Figure 1, arrowheads).
Contact precautions, such as cohorting and using new gloves
and gown when entering a patient’s room, were strictly
adhered to at time of observation; however, standard pre-
cautions were violated by several staff members during wound
and genital care. Specifically, we observed staff caring for
patients’ wounds and genital areas with the same washingbottles and ointments across multiple wards; a dental hygienist
using a portable suction device on multiple patients across
wards without proper cleaning or disinfection; and a vacuum
chip from the portable oral suction device being reused after
being washed with running water and disinfected with an un-
known concentration of diluted sodium hypochlorite solution
for an unknown period of time.
Thirty-eight strains of MDRP were isolated from several
environmental surfaces (e.g. bed rails, suction devices, naso-
gastric tubes, the junction of respirator tube and respirator
panel) before November 2013. After deep cleaning of the
hospital in November 2013, only four environmental strains
were isolated, all from samples obtained in the room of an
MDRP case.
The 23 patient isolates and the 12 strains from environ-
mental samples demonstrated a similar pattern of antimicro-
bial susceptibility: resistance to imipenem, meropenem,
gentamicin, tobramycin, amikacin, and ciprofloxacin; non-
susceptibility to ceftazidime (minimum inhibitory concentra-
tion: 4e32 mg/mL) and susceptibility to aztreonam. Eleven
patient isolates and four environmental isolates (a suction
tube, a suction brake, a nebulizer tube, and a bed bar) were
available for further study. These isolates were found to be
negative in combined disc tests for MBL and KPC production.
The screening for carbapenemases by a multiplex PCR revealed
that all isolates harboured the GES-type b-lactamase gene. A
BLAST analysis revealed that the PCR-amplified blaGES se-
quences had 100% identity with blaGES-5 in the GenBank
(accession no. GU831564). Furthermore, aacA4 genes were also
detected from the MDRP isolates. PFGE results indicated that
all of the analysed isolates from cases and environmental
samples were either indistinguishable or closely related with
high similarity (95%, Figure 2).9
Caseecontrol study
A total of 14 cases and 28 controls met the study definitions.
There were no significant difference between case and control
in terms of age, sex, and comorbidity as determined by McCabe
score. The time that the cases were at risk (72 days) was
significantly longer than that of controls (six days). After
adjustment for time at risk and comorbidities, use of an oxygen
mask (adjusted odds ratio: 23.0; 95% confidence interval:
2.1e250.4) and use of a nasogastric tube (17.1; 2.5e117.6)
were found to be significantly associated with MDRP infection.
Control measures
A specific response team was designated at the hospital and
was composed of the hospital’s infection control team (ICT)
and infection control experts from nearby hospitals. Infection
control measures had been implemented by an infection con-
trol practitioner before the outbreak, but they had not been
enough to control the outbreak.
To conduct active surveillance, sputum cultures were taken
from patients who required suctioning and wound cultures
were taken every month until April 2014. Stool, wound, and
urethral catheter screening cultures were taken for all hospi-
talized patients in January 2014. The use of the aforemen-
tioned devices that were shared among patients was
discontinued. The admission of patients to the hospital was
temporarily restricted for almost one month. During that
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Figure 1. The epidemic curve (by ward) of a multidrug-resistant Pseudomonas aeruginosa (MDRP) outbreak in a long-term acute care hospital in Japan, January 2013 to January
2014. Cases in which sputum samples were positive for MDRP are shown in white; other cases are shown in grey. Cases with strains that were found to be indistinguishable or closely
related by pulsed-field gel electrophoresis (PFGE) patterns are shown with asterisks. Cases in which an epidemiologic link was identified are circled with a dashed line; cases with
an unknown epidemiologic link are with hash marks. Cases who used portable suction devices are shown with arrow heads.
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Table I
Demographic data for 23 multidrug-resistant Pseudomonas
aeruginosa (MDRP) cases, January 2013 to January 2014
Total no. 23
Median age (years) 79
Sex
Male 17 (74%)
Female 6 (26%)
Underlying disease 23 (100%)
MDRP-positive specimen
Sputum 16 (70%)
Central venous catheter 2 (9%)
Wound 2 (9%)
Urethral catheter, blood 1 (4%)
Urine 1 (4%)
Stool 1 (4%)
Ward where MDRP-positive specimen was collected
Internal medicine ward 10 (43%)
Long-term care ward 5 (22%)
Surgery ward 1 4 (17%)
Surgery ward 2 3 (13%)
Outpatient 1 (4%)
Outcome
Death 11 (48%)
Alive 12 (52%)
Period from hospitalization to MDRP detection (days)
Median (range) 68 (8e1008)
60 70 80 90 10
0
Figure 2. Pulsed-field gel electrophoresis (PFGE) patterns of the
aeruginosa (MDRP) isolates. Pt, isolates from 11 cases; E, four environ
and a bed bar); ATCC27853, a standard strain of P. aeruginosa.
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regard to standard precautions, especially hand hygiene, were
reinforced, and the surveillance and alerting system for MDROs
was refined. A system of regular consultation on antimicrobial
prescriptions was initiated with the assistance of a local in-
fectious disease physician. Infection control practitioners at
nearby hospitals supported these control measures. The hos-
pital ICT decided to conduct a deep environmental clean during
the outbreak in November 2013. All of these control measures
were checked and supported by the local public health centre,
and no additional cases were found for one year after the last
reported case in January 2014.
Discussion
This work describes the successful control of an LTCF
outbreak of MDRP that harboured the novel blaGES-5 gene. The
outbreak was controlled by a range of infection control mea-
sures, including measures implemented by neighbouring hos-
pitals and a local public health centre.
Due to the ageing of populations in industrialized countries,
the number of LTCFs, which have been reported to be the
reservoirs for MDROs, is increasing.12,13 The resource-limited
setting of these facilities represents a major challenge for
MDRO infection control.14 It is therefore practical to prioritize
control measures in LTCFs. Because outbreaks of Gram-
negative bacteria are often caused by unsanitary medical de-
vices, we initially focused on stopping the sharing of devices
and on implementing standard precautions.15 Since 2012 in
Japan, co-operation among hospitals for infection control hasPt-1
Pt-2
Pt-3
Pt-4
Pt-5
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SpeI-digested genomic DNA of multidrug-resistant Pseudomonas
mental isolates (a suction tube, a suction brake, a nebulizer tube,
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universal health insurance policy. This framework makes it
possible for small-sized hospitals to obtain support from
experienced infection control practitioners in large, well-
resourced hospitals. This framework is also helpful for large-
sized hospitals because they can monitor the incidence of
MDROs in nearby hospitals and reduce the risk of imported in-
fections. Furthermore, local public health centres can play
pivotal roles in hospital networks by providing meeting places
or microbiological support through local public health labora-
tories. This framework was effective in controlling the
outbreak in the present investigation and has provided an
example of MDRO control in an LTCF.
GES-type b-lactamase was originally identified as a
cephamycin-hydrolysing extended-spectrum b-lactamase
family.16 Twenty-six variants of the GES group have been
identified, some of which are classified as carbapenem-
ases.16,17 GES-5 has been reported worldwide as a carbapen-
emase harboured by Klebsiella pneumoniae, Escherichia coli,
and P. aeruginosa.18 Prior to the outbreak described in this
report, only GES-3 and GES-4 had been detected in Japan (in
K. pneumoniae). The MDRP of the initial case was either ac-
quired within the community or imported from abroad. As this
is the first identification of GES-5 in Japan, we will be able to
monitor the possible spread of GES-5 in the surrounding area.
This caseecontrol study revealed that the use of nasogastric
tubes and oxygen masks was associated with MDRP acquisition
in the respiratory tract. Due to the possibility of recall bias, we
chose not to evaluate compliance with infection control prac-
tices among healthcare workers. Standard precautions in the
hospital were violated, however, and it is reasonable to
consider that the use of oxygen masks and nasogastric tubes
might have facilitated acquisition of MDRP in the respiratory
tract from contaminated healthcare worker hands.
In general, a number of devices appear to be associated with
MDRO acquisition, either due to the confounding effect or as a
consequence of poor hand hygiene. Since an increasing number
of devices are being used in LTCFs, healthcare workers should
consider carefully whether a certain medical device is neces-
sary for the patient before and during its use. Monitoring the
adherence to indicated use of these devices is critical for
infection control at such facilities.19
We hypothesized that cross-contamination due to poor hand
hygiene was the main cause of transmission and that sharing
unsanitary portable oral-care devices may have contributed to
transmission between wards. This device is equipped with a
disposable tip designed for personal use, not shared use be-
tween individuals. The complex structure of the tip hampers its
cleaning and disinfection. Previous reports have demonstrated
that nosocomial outbreaks of P. aeruginosa have been caused
by contaminated mouth swabs or reused bite blocks.20,21
Proper use of oral-care devices is an essential part of safe
oral-care practices. The provision of professional oral care by
dentists or dental hygienists is reportedly beneficial in pre-
venting pneumonia among older residents of LTCFs.22 Provision
of oral care to the elderly will become more widespread in
Japan, yet it has been reported that only 20e30% of dentists
are knowledgeable on standard precautions.23 Compliance
with infection control practices must be improved.
Our investigation has several limitations. First, the chro-
nology of risk factors and outcomes was unclear because we
could not precisely determine the timing of MDRP acquisition.Detection bias also exists in our caseecontrol study because
control selection was based on clinical samples. Second, the
molecular analysis was only conducted with MDRP isolates from
patients during the later period of the outbreak. Nevertheless,
MDRP was rare in this hospital and the surrounding area and it is
reasonable to consider that all isolates were clonal. Third, it is
difficult to assess infection control practices in the early stages
of an outbreak because of the potential for recall bias.
Although portable suction devices were shared among patients
across the wards, this was not recorded in a timely manner.
Thus, the true impact of oral care by portable suction device on
this outbreak cannot be determined.
In summary, an outbreak of MDRP with a new antimicrobial
resistant gene, GES-5, occurred in an LTCF. The outbreak was
controlled by prioritized control measures and support from
nearby, large hospitals. This experience serves as a good
example of the control of an MDRO outbreak in a facility in a
resource-limited setting.Acknowledgements
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